Showing results (261-270 of 426) with videos related to

Sort By:
Pageof 43
ESMO Open|July 24, 2025
Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implicationsG Griguolo, M V Dieci, S Fineberg, et al.
British Journal of Cancer|October 19, 2020
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort studySaur Hajiev, Elias Allara, Leila Motedayеn Aval, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|October 24, 2017
Catechol-O-Methyltransferase (COMT) Val158Met Polymorphism and Eating Disorders: Data From a New Biobank and Meta-Analysis of Previously Published StudiesEnrico Collantoni, Marco Solmi, Davide Gallicchio, et al.
Cell Reports. Medicine|June 22, 2023
Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancerHaonan Lu, Hantao Lou, Georg Wengert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA TrialMaria Vittoria Dieci, Valentina Guarneri, Anna Tosi, et al.
JAMA Oncology|September 2, 2021
COVID-19 and Cancer: A Review of the Registry-Based Pandemic ResponseAakash Desai, Turab J Mohammed, Narjust Duma, et al.
Frontiers in Oncology|June 16, 2023
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysisShobana Anpalakhan, Prerana Huddar, Roya Behrouzi, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|June 1, 2000
[Epidural spinal stimulation in the treatment of refractory angina pectoris. Its clinical efficacy, complications and long-term mortality. An Italian multicenter retrospective study]M Romanò, A Auriti, R Cazzin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancerSarah Blagden, Aurelius Omlin, Aurelius Olmin, et al.
Viruses|January 8, 2025
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?Carlo Smirne, Maria Grazia Crobu, Irene Landi, et al.
Pageof 43